Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiodermatitis 3 Head and Neck Neoplasms 3 Hypotension 2 Stroke 1 Shock, Septic 1 Optimal Tissue Perfusion 1 Neoplasms 1 Mouth Neoplasms 1 Leiomyoma 1 Brain Neoplasms 1 Alopecia 1

Interventions

Cisplatin 30 Magnetic Resonance Spectroscopy 21 Radiotherapy 20 pembrolizumab 18 Specimen Handling 17 Cetuximab 16 Biopsy 13 Radiotherapy, Intensity-Modulated 12 Radiation 11 Paclitaxel 11 Carboplatin 11 Surveys and Questionnaires 10 Fluorouracil 10 Drug Therapy 10 1,2-diaminocyclohexaneplatinum II citrate 10 Platinum 9 Surgical Procedures, Operative 8 X-Rays 7 Taxes 7 Celecoxib 7 Standard of Care 6 Sentinel Lymph Node Biopsy 6 Observation 5 Nivolumab 5 cemiplimab 4 Metformin 4 Interviews as Topic 4 Immunohistochemistry 4 Fluorodeoxyglucose F18 4 Docetaxel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mouth Neoplasms × Norepinephrine × Clear all

NCT01418118 2011-08-16

Free4Flow

Oxford University Hospitals NHS Trust

Phase 4 Completed

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡